Compare IOBT & CFND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOBT | CFND |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Denmark | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6M | 27.4M |
| IPO Year | 2021 | 2025 |
| Metric | IOBT | CFND |
|---|---|---|
| Price | $0.34 | $4.05 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.25 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 31.7K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $3.82 |
| 52 Week High | $2.79 | $9.67 |
| Indicator | IOBT | CFND |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 29.97 |
| Support Level | $0.35 | $3.98 |
| Resistance Level | $0.39 | $4.22 |
| Average True Range (ATR) | 0.04 | 0.24 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 75.88 | 8.79 |
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.